␤-Amyloid (A␤) acquires toxicity by self-aggregation. To identify and characterize the toxic form(s) of A␤ aggregates, we examined in vitro aggregation conditions by using large quantities of homogenous, chemically synthesized A␤1-40 peptide. We found that slow rotation of A␤1-40 solution reproducibly gave self-aggregated A␤1-40 containing a stable and highly toxic moiety. Examination of the aggregates purified by glycerol-gradient centrifugation by atomic force microscopy and transmission electron microscopy revealed that the toxic moiety is a perfect sphere, which we call amylospheroid (ASPD). Other A␤1-40 aggregates, including fibrils, were nontoxic. Correlation studies between toxicity and sphere size indicate that 10-to 15-nm ASPD was highly toxic, whereas ASPD <10 nm was nontoxic. A positive correlation between the toxicity and ASPD >10 nm also appeared to exist when A␤1-42 formed ASPD by slow rotation. However, A␤1-42-ASPD formed more rapidly, killed neurons at lower concentrations, and showed Ϸ100-fold-higher toxicity than A␤1-40-ASPD. The toxic ASPD was associated with SDS-resistant oligomeric bands in immunoblotting, which were absent in nontoxic ASPD. Because the formation of ASPD was not disturbed by pentapeptides that break ␤-sheet interactions, A␤ may form ASPD through a pathway that is at least partly distinct from that of fibril formation. Inhibition experiments with lithium suggest the involvement of tau protein kinase I͞gly-cogen synthase kinase-3␤ in the early stages of ASPD-induced neurodegeneration. Here we describe the identification and characterization of ASPD and discuss its possible role in the neurodegeneration in Alzheimer's disease.
A 40 -to 42-residue peptide named ␤-amyloid (A␤) is a major constituent of senile plaques in Alzheimer's disease (AD) (1) . Although multiple pathways have been suggested to lead to AD, recent advances indicate a causal link between A␤ and AD (2) , and this idea is supported further by findings that vaccination against A␤ ameliorates behavioral deficits in transgenic mice (3) (4) (5) . Among various in vivo A␤ species, A␤ generally is considered as the primary vehicle of toxicity, whereas A␤ 1-40 , a major species under physiological conditions, is considered less harmful and more resistant to the formation of oligomers than A␤ (6) . However, it remains controversial which A␤ species contributes predominantly to AD pathogenesis, because both in vitro and in vivo studies have confirmed toxicity of A␤ aggregates (7, 8) .
It has been widely accepted that toxicity of A␤ requires aggregation of native A␤ monomers (9) (10) (11) . Besides fibrils, several types of nonfibrillar aggregates have been reported: A␤ oligomers from dimers-hexamers (6, (12) (13) (14) ; a mixture of A␤ oligomers named A␤-derived diffusible ligands (ADDLs), ranging from trimers-hexamers up to 24-mers (15) ; and fibril intermediates named protofibrils (PFs) (16, 17) . All of these aggregates are mixtures of A␤ oligomers with a variety in oligomer size, and precise morphological analysis of each A␤ aggregate is difficult. In other words, the heterogeneity of A␤ aggregates in terms of A␤ species and oligomer size makes it difficult to reach a consensus about the oligomerization state of A␤ causing the pathogenicity. It is yet to be determined whether all of these in vitro oligomers actually exist in vivo and induce neuronal damage, or whether a particular oligomer is primarily responsible for AD.
To identify and characterize the toxic forms of A␤ aggregates, we first examined in vitro aggregation conditions by using the chemically synthesized A␤ and found that slow rotation of A␤ solution reproducibly gave A␤ aggregates containing a stable and highly neurotoxic moiety. Purification of the toxic moiety revealed that it is a perfect sphere, which we call amylospheroid (ASPD). Other moieties, including fibrils, were nontoxic. Second, we applied the above conditions to A␤ and compared A␤ -ASPD with A␤ 1-40 -ASPD. Finally, we used lithium to examine whether there is a link between ASPD toxicity and activation of glycogen synthase kinase-3␤ (GSK-3␤) (18) , which also is known as tau protein kinase I (TPKI) (19) . Here, we describe the identification and characterization of ASPD and discuss its potential involvement in AD.
Materials and Methods
Synthesis of A␤s. A␤ and A␤ 16 -20 were synthesized and purified in Mitsubishi Kagaku Institute of Life Sciences by solid-phase fluorenylmethoxycarbonyl chemistry (Ͼ50% yield). Amino acid analysis, analytical HPLC, and matrix-assisted laser desorption ionization-time-of-flight mass spectrometry confirmed the purity of the products. The purified A␤s were lyophilized, dissolved in 35% CH 3 CN in 0.1% trifluoroacetic acid, distributed into Eppendorf tubes (0.1 mol), lyophilized, and kept at Ϫ20°C until used. A␤ 16 -20 (KLVFF) (20) or iA␤5 (LPFFD) (21) (Peptide Institute, Osaka), A␤ solutions were mixed with a 10-fold molar excess of the pentapeptides at the onset of slow rotation.
Preparation and Purification of A␤1-42-ASPD. Toxic A␤ aggregates were prepared from A␤ (Bachem) in essentially the same way as from A␤ , by slowly rotating A␤ 1-42 solutions (1-0.01 M in 50% PBS) at 4°C for 8-10 h. A␤ 1-42 -ASPD was purified from SR 0.1 -A␤ 1-42 by using glycerol-gradient centrifugation as described above.
Transmission Electron Microscopy of ASPD. The isolated ASPD was negatively stained with 4% uranyl acetate solution on carboncoated grids, analyzed immediately by JEOL JEM-1200EX͞Top at 100 kV with an anticontamination system under liquid nitrogen, and photographed by using a minimum-dose system to prevent radiation damage. The size of ASPD was determined by NIH IMAGE or by measuring the diameter at the equator with a micrometer. Both methods gave similar results. In the case of unstained ASPD, ASPD was mixed with type VII agarose (1.0%; Sigma), fixed with 4% glutaraldehyde͞PBS for 2 h, and embedded in Epon 812 resin (22) . A horizontal thin section was made from the resin, and a cross section was made from a horizontal section, adjacent to the first one, reembedded in the resin. Both sections were examined by JEOL JEM-1230 at 100 kV.
Fluid-Phase Imaging of ASPD by Atomic Force Microscopy. The isolated ASPD was deposited on freshly cleaved mica (Nihon Veeco KK, Tokyo) that was modified with 3-aminopropylethoxysilane (23) and left for 30 min. Imaging was performed under 50% PBS by a multimode microscope with a Nanoscope III controller in a tapping-mode fluid cell (Digital Instruments, Santa Barbara, CA) by using A-scanner with 700-nm maximum lateral scan area. Silicon nitride probes coated with 0.5% polyethyleneimine (0.15 M borate buffer), attached to a 100-m triangular cantilever (force constant of 0.08 N͞m; Olympus, New Hyde Park, NY), were operated at 9-kHz resonant frequency with 0.5-Hz scan rates. Images were captured at 256 ϫ 256 pixels.
Toxicity Assays. Primary cultures from rat septum regions, which include septal and basal forebrain cholinergic neurons, were prepared, and the medium (400 l per well) was replaced with serum-free medium after 3 days in vitro (24) . After 5 days in vitro, cultures were treated with either slowly rotated A␤ 1-40 solution (SR-A␤) or ASPD. After a 16-h treatment, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) activity, a toxicity indicator (25, 26) , was determined by measuring the absorbance at 570 nm. The background value was obtained by lysing cells with 0.1% Triton X-100 treatment for 10 min. Toxicity was estimated as inhibition of MTT activity compared with the control value obtained upon vehicle addition. After a 40-h treatment, cultures were rinsed and exposed for 30 min to propidium iodide (5 M) and calcein-AM (0.2 M) in 20 mM Hepes (pH 7.3) containing 130 mM NaCl, 5.4 mM KCl, 5.5 mM glucose, and 2 mM CaCl 2 at 37°C. Dye uptake was measured by using Zeiss Axiovert 200M with CoolSNAP HQ (Roper Scientific, Trenton, NJ) and analyzed with MetaMorph (Molecular Devices). Cells with shrunken or fragmented nuclear staining were counted as dead cells. The total cell number was assessed by Hoechst 33258 (1 g͞ml) staining after 10% formalin fixation. At least 1,200 cells were selected randomly from four different fields. Apoptotic activity was expressed as the ratio of apoptotic cells to the total cell number.
TPKI͞GSK-3␤ Kinase Activity. Cultures were disrupted after the treatment, and TPKI͞GSK-3␤ activity was determined (24) .
Immunoblotting. Samples were separated on NOVEX 10-20% Tris͞N-[tris(hydroxymethyl]glycine gels (Invitrogen). Immunoreactive bands with 4G8 (1 g͞ml; Signet Laboratories, Dedham, MA) were detected (27) by using SuperSignal West Femto substrates (Pierce).
Statistics. We examined the statistical significance of differences between groups by applying Games-Howell post hoc tests, using STATVIEW 5.0 (SAS Institute, Cary, NC).
Results

Preparation and Identification of Spherical A␤1-40 Aggregates (ASPD)
as a Highly Toxic Moiety Among A␤1-40 Aggregates. We chemically synthesized A␤ to obtain large quantities of homogenous peptide as starting material. After purification and characterization, A␤ 1-40 dissolved in 50% PBS to 350 M was allowed to self-aggregate under various conditions, and the toxicity of each A␤ solution was estimated by MTT activity by using primary cultures from rat septum regions. Initially, A␤ 1-40 solutions were nontoxic. When A␤ 1-40 solutions (Fig. 1A) were rotated slowly for 5-7 days, they showed potent toxicity at 0.1 M. Without slow rotation, A␤ 1-40 solution remained nontoxic even at 5 M (Fig.  1 A) . Therefore, we prepared toxic A␤ aggregates by slowly rotating A␤ solutions (350 M in 50% PBS); the aggregates thus prepared are designated as SR 350 -A␤ .
To identify the toxic moiety in SR 350 -A␤ 1-40 , we examined the structure-toxicity relationship of A␤ aggregates during the course of slow rotation. A␤ aggregates first detected by transmission electron microscopy consisted of spherical structures 3-20 nm in diameter without any detectable fibrils (Fig. 1B,  4 h). At 27 h, short, straight fibers and PF-like structures were detected, which disappeared when 6-to 10-nm-wide fibrils were formed at 75 h, whereas spherical structures continued to exist ( We inhibited the fibril formation by pentapeptides containing the A␤ 16 -20 motif, which break ␤-sheet interactions required for the fibril formation. As reported previously, addition of A␤ 16 -20 (KLVFF) (20) or iA␤ 5 (LPFFD) (21) at the onset of slow rotation led to Ϸ70% reduction in fibrils in SR 350 -A␤ 1-40 in thioflavine T assay. However, toxicity of SR 350 -A␤ 1-40 was unchanged (Fig. 1D) . Slow rotation of the pentapeptides alone did not yield any toxicity. These results (Fig. 1 B-D ) strongly suggest that A␤ aggregates other than fibrils are responsible for the toxicity in SR-A␤ . We obtained similar results by using A␤ from Bachem or U.S. Peptide.
In contrast to the fibril, the spherical structure (Fig. 1B, 4 h) was not affected by the pentapeptides (Fig. 1D ) and was present in SR-A␤ 1-40 even under conditions in which fibrils were rarely detected owing to low A␤ concentrations. These results suggest that the spherical structure is the toxic moiety in SR-A␤ . In the following text, this spherical structure, a candidate neurotoxin in SR-A␤ , is designated as ASPD.
Morphology and Neurotoxicity of ASPD Isolated from SR-A␤1-40.
ASPD was isolated in the flowthrough fraction of filters with 0.65-M and 30-kDa molecular sieves, which contained only ASPD ranging from 4 to 18 nm (10.4 Ϯ 2.9 nm on average, n ϭ 101) with no fibrils (Fig. 2A) . Based on measurement of the ''width'' and ''length'' of each ASPD in Fig. 2 A, simple regression analysis was performed: y͞x ϭ 0.982, r 2 ϭ 0.869, ⌬mean (width Ϫ length) ϭ Ϫ0.1628 and ⌬ (width Ϫ length) ϭ 0.7. These values support that ASPD is perfectly spherical. ASPD in the resin also gave circular images in both horizontal and cross sections (Fig. 2B) , suggesting that ASPD is indeed a sphere.
To avoid possible effects of sample drying, which was necessary for transmission electron microscopy, the isolated ASPD was visualized in 50% PBS by atomic force microscopy. The shape of the section curve is consistent with a spherical shape of ASPD (Fig. 2C) . Furthermore, a statistical analysis was carried out. In atomic force microscopy, the height is obtained precisely, whereas the length or the width is larger than the real value owing to effects depending on the radius of the probe. The radius of the probe (R) used here was estimated to be Ϸ2.5 nm (data not shown). If the sample is a sphere, its diameter (2r) can be calculated from the measured half-width (D) by using the following equation: 2r ϭ Ϫ2R ϩ 2 ͌ R 2 ϩ D 2 ͞4. We measured the height and the half-width of each ASPD and obtained the height͞calculated diameter ratio of each ASPD, which was 1.0 on average (n ϭ 100) (Fig. 2C) . These results confirmed that ASPD is a sphere, not a disk or a cylinder.
A 40-h treatment of neuronal cultures with the isolated ASPD (210 nM in A␤ 1-40 monomer concentration) resulted in Ϸ40% neurodegeneration, with the remaining neurons displaying dis- integrated neurites (Fig. 2D Top and Fig. 2D Bottom) , the isolated ASPD caused statistically significant inhibition of MTT activity (GamesHowell post hoc tests, n ϭ 6). The isolated ASPD was stable over 2 months at 4°C and did not change to fibrils during another 7-day slow rotation. These results suggest that ASPD directly induced neurodegeneration.
Purification of the Toxic ASPD by Using Glycerol-Gradient Centrifugation. We purified ASPD further as in Fig. 3A by centrifugation (86,000 ϫ g, 16 h) of SR 350 -A␤ 1-40 in a 15-30% linear glycerol gradient. Immediately after the centrifugation, the apoptotic activity and the A␤ content of each fraction were evaluated, and the specific cell death activity in Fig. 3B was calculated from these values that were obtained in four independent experiments. We found that ASPD was distributed into two groups: toxic ASPD recovered in the bottom-most part of the gradient and nontoxic ASPD recovered in the upper part of the gradient (Fig.  3B) . In repeated experiments, ASPD with the highest toxicity was found reproducibly in fraction 2 around the migration position of thyroglobulin (669 kDa). The toxic ASPD induced apoptosis in neuronal cultures after a 40-h treatment, whereas nontoxic ASPD in fraction 11 did not (Fig. 3B Inset) . ASPD in fraction 2 showed an Ϸ450-fold-higher toxicity than fibrils and an Ϸ80-fold-higher toxicity than SR 350 -A␤ (Fig. 3B) .
Using ASPD purified by the glycerol gradient, we examined whether a correlation exists between the size of ASPD and its toxicity. The particle analysis of each fraction (Fig. 3C) clearly indicates that toxic ASPD consisted of particles Ͼ10 nm in transmission electron microscopy and nontoxic ASPD consisted of those Ͻ10 nm. ASPD in fraction 3 was Ͻ15 nm but exhibited toxicity equal to that of ASPD in fraction 1 (Fig. 3 B and C) . Toxicity was absent in the flowthrough fraction of a filter with a 5-kDa molecular sieve size, suggesting a minor contribution to the toxicity from monomer or small oligomers that cannot be detected in transmission electron microscopy. Although there is still a possibility that species present in amounts too small to detect are involved, these results taken together indicate that potent toxicity is correlated best with 10-to 15-nm ASPD.
The toxic ASPD and nontoxic ASPD differed not only in apparent particle size but also in their band pattern in immunoblotting. As in Fig. 3B , at the onset of slow rotation, A␤ freshly dissolved in 50% PBS gave only a monomeric band, eluting as a single peak at a retention time corresponding to A␤ 1-40 dimer in size-exclusion chromatography by using a Superdex 75 column (refs. 12, 17, and 29 and data not shown). After a 7-day slow rotation, SDS-stable oligomeric bands up to tetramers appeared in SR 350 -A␤ (Fig. 3B, arrowheads) , suggesting a change in the nature of A␤ . After glycerol-gradient centrifugation, the toxic ASPD in fractions 1-3 contained these SDS-stable oligomeric bands, but nontoxic ASPD did not (Fig.  3B Upper) .
We applied the conditions established for A␤ to longer, more hydrophobic A␤ , which generally is considered to be more pathogenic than A␤ . Toxic A␤ aggregates were prepared by slowly rotating A␤ 1-42 solutions (1-0.01 M in 50% PBS) and were fractionated by using glycerol-gradient centrifugation. ASPD-like spheres with 3-to 20-nm diameters were detected after at least an 8-h slow rotation ( Fig. 3D Left) ; they killed neurons at Ϸ0.35 nM (40-h treatment). In repeated fractionations, the highest toxicity was recovered reproducibly in fraction 2 (n ϭ 7), Ϸ70% of which was accounted for by 10-to 14-nm ASPD-like spheres as shown by particle analysis (Fig. 3D   Right) . The specific cell death activity of A␤ 1-42 -ASPD in fraction 2 was estimated to be at least Ϸ100-fold higher than that of A␤ 1-40 -ASPD in fraction 2. In the case of A␤ 1-40 , formation of toxic ASPD requires a longer period of slow rotation with decrease in the initial concentration of A␤ : it took 4 h at 350 M but Ͼ30 h at 50 M. A␤ 1-42 at lower concentrations formed ASPD much earlier than A␤ 1-40. These results demonstrated that A␤ forms ASPD, as A␤ , but A␤ 1-42 -ASPD is formed more rapidly, induces neurodegeneration at lower concentrations, and is more toxic than A␤ 1-40 -ASPD.
Toxicity of ASPD May Involve TPKI͞GSK-3␤ Activation. We found a rapid increase in TPKI͞GSK-3␤ activity in ASPD-treated neuronal cultures, which reached its maximum (Ϸ2.8-fold) after a 2-h treatment, followed by a decline to a level 50% higher than that of the control (Fig. 4A Upper) . TPKI͞GSK-3␤ plays a crucial role in A␤-triggered neuropathological cascades (19, 24, 30) . Lithium has been suggested recently as a possible therapeutic reagent for AD, because of its ability to inhibit TPKI͞GSK-3␤ activity (31, 32) . Thus, we examined whether inhibition of TPKI͞GSK-3␤ by lithium protects neurons against ASPD toxicity. Lithium suppressed the ASPD toxicity in a dose-dependent manner with an IC 50 of Ϸ2 mM (Fig. 4B) , which is similar to the reported IC 50 of lithium on TPKI͞GSK-3␤ activity (33) . The addition of 2 mM lithium within 1 h after ASPD treatment protected cells against ASPD toxicity but had no effect 4 h after ASPD treatment (Fig. 4A Lower) . Protective effects of lithium were confirmed further by using propidium iodide and Hoechst 33258 staining; in the presence of 2 mM lithium, apoptotic cell death induced by 210 nM ASPD was decreased significantly, nearly to the control level (Fig. 4C) . These findings raise the possibility that TPKI͞GSK-3␤ is involved in the early stages of the ASPD-induced neurodegenerative cascades.
Discussion
It is generally accepted that amyloids play a crucial role in neurodegenerative diseases such as AD. Nevertheless, the physiological function of A␤s has not been elucidated. There are several reasons for this. For example, A␤s in the in vivo state are not homogeneous but are mixtures of peptides with different sizes. Although A␤ 1-40 is predominant among them (34) , accumulated data have indicated that A␤ 1-42 is the strongest candidate for the neurotoxic agent. In addition, the aggregation states of these peptides are controversial. Some reports suggest that fibrils are toxic, but others support dimer or oligomer as the real neurotoxin (reviewed in ref. 35) . To avoid such ambiguities, we chemically synthesized large amounts of homogeneous A␤ . Although the solution of this preparation was not toxic, we found by chance that slow rotation of A␤ 1-40 solution for 5-7 days converted A␤ to a stable form with potent toxicity (Fig. 1B) . Purification and characterization of the toxic moiety provided evidence that a perfectly spherical A␤ aggregate is the most probable origin of the observed toxicity (Figs. 2 and 3) . Other A␤ aggregates, including fibrils, were nontoxic. Therefore, we designated this toxic A␤ 1-40 aggregate as ASPD. Correlation analysis in Fig. 3 indicated that toxicity is most closely associated with 10-to 15-nm ASPD, whereas ASPD Ͻ10 nm was nontoxic. We also found that A␤ forms ASPD, but A␤ 1-42 -ASPD is formed more rapidly, induces neurodegeneration at a lower concentration (Ϸ0.35 nM), and exhibits Ϸ100-fold-higher toxicity than A␤ 1-40 -ASPD. Further analysis is required to elucidate the molecular basis of these differences. Because so far it is largely unknown how ASPD exerts its effect on neurons, we cannot completely rule out the possibility that very minor oligomers that have escaped detection are responsible for the toxicity. However, the data obtained up to the present support a positive correlation between the toxicity and ASPD Ͼ10 nm in the case of both A␤ 1-40 -ASPD and A␤ 1-42 -ASPD (Fig. 3) as well as when toxic ASPD in fraction 2 of the glycerol gradient was separated further by using size-exclusion chromatography (A.N., M.S., and M.H., unpublished data). Furthermore, the toxicity was not recovered in the f lowthrough fraction of a filter with a 5-kDa molecular sieve size, suggesting that the toxicity is not attributable to monomer or small oligomers that cannot be detected in transmission electron microscopy.
PFs and ADDLs are two representative in vitro nonfibrillar neurotoxins detected by transmission electron microscopy or atomic force microscopy. Spherical ASPD is obviously different from curvilinear PFs (4-to 11-nm diameter and Ͻ200-nm length) (16, 17) . ADDLs are a mixture of A␤ oligomers from trimers-hexamers up to 24-mers (15, 35) . Because toxicity of ADDLs has been assessed in oligomer mixtures, it is difficult to know the precise size of the toxic moiety in ADDLs (15) . The major component of ADDLs appeared to be globules of 4.8 -5.7 nm in atomic force microscopy with 17-and 22-kDa bands in immunoblotting (15) . We could not find any correlation between the toxicity and spheres of Ϸ5 nm derived from A␤ or A␤ in glycerol-gradient fractionation. ASPD showed an apparent size of 9.2 nm on average in atomic force microscopy and contained SDS-stable oligomeric bands up to tetramers. Formation of ADDLs seems to be restricted to A␤ when fibril formation is suppressed (15) , whereas ASPD is formed from either A␤ or A␤ 1-42 irrespective of fibril formation. Thus, ASPD differs from ADDLs in size, the band composition in immunoblotting, and preparation method. Under the conditions examined, A␤ remained nontoxic without slow rotation (Fig. 1 A) . Slow rotation has been reported to enhance the aggregation of yeast prion (36) or hemoglobin S (37). Because ASPD is formed below the concentration required for fibril formation and in the presence of ␤-sheet-breaking peptides ( Fig. 1 C and D) , A␤ may aggregate into ASPD, at least in part, through a distinct pathway from fibril formation. Thus, it is possible that slow rotation of A␤ solution leads to some as-yet-unknown structural changes in A␤ that induce spherical aggregation, because SDS-stable oligomeric bands of A␤ are seen only in toxic ASPD. Further studies are required to understand the aggregation process of A␤ into ASPD and the relationship of ASPD with fibrils and other nonfibrillar oligomers.
Recent in vivo as well as in vitro studies support the toxicity of nonfibrillar oligomers and their possible causative role in neuropathology in AD (8, 35, 38) , which is consistent with the dissociation between fibril loads and the cognitive decline in AD (39) (40) (41) . Because vaccination, in some cases, has protected transgenic mice from memory loss without a significant decrease in A␤ fibril loads (5), A␤ aggregates other than fibrils may be the preferred therapeutic targets for AD (35) . However, the nature of A␤ species and the oligomer state responsible for the pathogenesis remain controversial owing to the heterogeneity of A␤ aggregates in terms of A␤ species and oligomer size. Fractionation studies using an in vitro A␤ aggregation system as shown here will help to elucidate the aggregation process and to determine the oligomerization state of A␤ causing the pathogenesis.
In AD brains, intracellular accumulation of nonfibrillar A␤, especially A␤ (42, 43) , precedes the extracellular fibrillar accumulation of A␤ as senile plaques (1) . Recently, LeBlanc et al. (44) have shown that microinjection of A␤ 1-42 kills neurons. In their experiments, extracellular treatment of neurons with A␤ or A␤ did not affect the viability, despite the reported toxicity. These findings indicate the biological significance of intracellular A␤ accumulation but, at the same time, also raise the question of the source of intracellular A␤ in vivo (44): how does A␤, which is produced through the secretory pathway, enter the cytosol? In our preliminary experiments, SDS-resistant oligomeric bands could be detected by immunoblotting in cytosolic extracts of neuronal cultures within 1 h after extracellular ASPD treatment (M.H. and M.S., unpublished data). If A␤ really exerts its effect intracellularly, variability in biological activities among in vitro identified A␤ aggregates may be attributed to their differing ability to access the cytosol. Future experiments to examine how ASPD enters the cytosol may provide some clue to the apparent contradiction between intracellular and extracellular A␤ accumulation.
Lithium, one of the most widely used drugs for bipolar disorder, protects neurons against suboptimal conditions or from excitotoxicity-induced lesions (reviewed in ref. 45 ). Here, we found that lithium may protect neurons in the early phase of ASPD treatment, perhaps through inhibition of TPKI͞GSK-3␤ activation. Possible use of lithium as a therapeutic reagent for AD has been suggested by several authors (31-33, 46, 47) . Considering the important role of TPKI͞GSK-3␤ in AD, more detailed studies on the molecular mechanism of the lithium protection against ASPD may help to design inhibitors of TPKI͞GSK-3␤ as candidate drugs for the treatment of AD.
